Exane Derivatives’s VEON VEON Stock Holding History

Exane Derivatives’s Portfolio VEON Stock Details VEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Hold	0	–	-$2	–	721
2019 Q1	–	Sell	-86	Closed	-$5.37K	–	635
2018 Q4	$5.06K	Hold	86	–	–	﹤0.01%	494
2018 Q3	$6.29K	Sell	86 -4,342	-98%	-$315K	﹤0.01%	456
2018 Q2	$265K	Buy	4,428 +4,000	+935%	+$250K	0.04%	235
2018 Q1	$28K	Hold	428	–	–	0.01%	382
2017 Q4	$41.1K	Hold	428	–	–	0.01%	356
2017 Q3	$44.8K	Hold	428	–	–	0.01%	315
2017 Q2	$41.9K	Buy	+428	New	+$42.2K	0.01%	326
2017 Q1	–	Sell	-577	Closed	-$55.6K	–	683
2016 Q4	$55.6K	Buy	+577	New	+$49.9K	0.01%	291

Other funds holding VEON

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Prosperity Capital Management Camana Bay, Cayman Islands $83.6M AUM 26.3% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

TT International London, United Kingdom $1.94B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

PCP

Polunin Capital Partners London, United Kingdom $407M AUM 55.12% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Exane Derivatives's VEON Position: Q2 2019 in Review

Exane Derivatives held its VEON (VEON) position steady in Q2 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #721.

Exane Derivatives first reported a position in VEON in Q4 2016 and has held it in 8 quarters since. The position peaked at $265K in Q2 2018. 117 funds tracked by Wall St. Rank hold VEON as of Q2 2019.

Exane Derivatives held 0 shares of VEON worth $0 as of Q2 2019.
Exane Derivatives left its VEON share count unchanged in Q2 2019.
VEON made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2019, its #721 holding.
Exane Derivatives first reported a position in VEON in Q4 2016 and has held it in 8 quarters since.
Exane Derivatives's VEON position peaked at $265K in Q2 2018.
117 funds tracked by Wall St. Rank held VEON as of Q2 2019.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.